CDRE Cadre Holdings, Inc.
Data as of close
Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Cadre Holdings, Inc. (CDRE) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $1.4 billion. Shares last traded at $31.55, 36.9% below their 52-week high. Over the past year the stock is down 26.0%. CDRE trades at a price-to-earnings ratio of 37.46, above the Orthopedic, Prosthetic & Surgical Appliances & Supplies median of 26.48. Net profit margin is 5.3%, in line with the peer median of 5.3%. Revenue grew 7.5% year over year. The shares yield 1.2% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
CDRE Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-12-31 | $15M | $0.36 | 35% |
| 2024-12-31 | $14M | $0.35 | 39% |
| 2023-12-31 | $12M | $0.32 | 31% |
| 2022-12-31 | $12M | $0.32 | 198% |
| 2021-12-31 | $13M | $0.45 | 101% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $0.26 | 2026-08-05 |
| Q1 2026 | $0.05 | 2026-05-11 |
| Q4 2025 (derived) | $0.22 | 2026-03-10 |
| FY 2025 | $1.02 | 2026-03-10 |
| Q3 2025 | $0.27 | 2025-11-04 |
| Q2 2025 | $0.30 | 2025-08-05 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Orthopedic, Prosthetic & Surgical Appliances & Supplies peers
CDRE vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap. Data as of close
| ISRG | Intuitive Surgical | $151.5B | 51.23 | 13.08 | 25.5% | +1.13% |
| EW | Edwards Lifesciences | $53.7B | 53.49 | 8.25 | 15.4% | +1.35% |
| STE | Steris | $22.7B | 28.25 | 3.77 | 13.3% | +2.70% |
| ZBH | Zimmer Biomet | $18.6B | 23.01 | 2.18 | 9.5% | +2.98% |
| ALGN | Align Technology | $11.0B | 26.48 | 2.65 | 10.0% | +2.86% |
| MSA | Msa Safety Inc | $7.2B | 22.98 | 3.71 | 16.1% | +4.76% |
| ESTA | Establishment Labs Holdings Inc. | $1.8B | — | 7.40 | -15.8% | -2.14% |
| CDRE | Cadre Holdings, Inc. | $1.4B | 37.46 | 1.97 | 5.3% | +4.02% |
| ENOV | Enovis Corp | $1.2B | — | 0.52 | -48.0% | +3.51% |
| AVR | Anteris Technologies Global Corp. | $562M | — | 250.82 | — | -8.63% |
| SMTI | Sanara MedTech Inc. | $296M | — | 2.69 | -29.2% | -1.98% |
| INGN | Inogen Inc | $182M | — | 0.60 | -8.1% | +0.00% |
| LAKE | LAKELAND INDUSTRIES INC | $89M | — | 0.47 | -14.0% | +1.24% |
| NTRB | NutriBand Inc. | $77M | — | — | — | +1.04% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.